… -small cell lung cancers (NSCLCs). Vasculogenic mimicry (VM), the formation of vascular
networks composed of aggressive cancer cells, may be one of the reasons. our study explored …

… Tumor cells transform into endothelial cells by epithelial-to-mesenchymal transition, which
is characterized by vasculogenic mimicry (VM). VM not only accelerates tumor progression …

… Prevalent circulating tumor cells (CTCs) is one of the characteristic of small cell lung cancer
(… kinase induces VM formation in non-small-cell lung cancer by activating of the FAK and AKT …

… tumor metastasis, and vasculogenic mimicry (VM) is an important form of neovascularization
found in highly invasive tumors, including lung cancer. … Non-small cell lung cancer (NSCLC) …

… Vasculogenic mimicry refers to the ability of cancer cells to organize themselves into
vascular-like structures for the obtention of nutrients and oxygen independently of normal blood …

… In lung cancer, the estrogen receptor β interacts with different estrogen response elements …
145-5p and linked to non-small cell lung cancer metastasis). This promotes VM formation and …

… or HIF molecules promote the VM process in multiple tumor types including cervical cancer
[13], small cell lung cancer [14], liver cancer [15], and gallbladder cancer [16]. HIF-1 can also …

… A recent study reported that VE-cadherin-positive small cell lung cancer (SCLC) cells
were able to show VM and were more resistant to cisplatin than VE-cadherin negative …

… non-small cell lung cancer … The two types of vascular mimicry. A) Patterned vasculogenic
mimicry (VM) forms architectural patterns of loops and networks as revealed by periodic acid-…

… the progression of non-small cell lung cancer (NSCLC), its linkage to alteration of the
vasculogenic mimicry (VM) formation to influence the NSCLC cell invasion remains unclear. Here, …